priority meds semaglutide The U.S. health regulator asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound. https://cnn.it/49uSrKw F.D.A. Approves New Obesity Drug

CrossRef Direct-acting Antivirals Therapy for Hepatocellular Carcinoma in Hepatitis C Patients Seul Ki Han, Soon Koo Baik, Moon Young Kim Journal of Digestive Cancer Research .2025

The Math: Calculating Your Melanotan 2 Concentration This is where many researchers, especially those new to peptides, feel a bit of anxiety

Although both peptides have been studied in the context of wound healing and inflammation control, they appear to influence tissue repair through different biochemical entry points

Last year alone, 43% of employers covered weight loss drugs like Ozempic and Wegovy, nearly doubling year-over-year

Common side effects include nausea, diarrhea and stomach pain

This finding may influence dosing recommendations for people with obesity